Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-20-001337
Filing Date
2020-05-26
Accepted
2020-05-26 15:03:44
Documents
2
Period of Report
2020-05-20

Document Format Files

Seq Description Document Type Size
1 form4-05262020_120530.html 4  
1 form4-05262020_120530.xml 4 4214
2 ex24-05262020_120531.htm EX-24 6906
  Complete submission text file 0001415889-20-001337.txt   12756
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address OPKO HEALTH, INC. 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address
Rubin Steven D (Reporting) CIK: 0001381874 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 20909962